NLS Pharmaceutics AG
(NLSPW)
undefined
undefined%
At close: undefined
0.01
0.00%
After-hours Dec 13, 2024, 03:41 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -18.44 | -15.39 | -13.70 | -48.67 | -59.11 | -66.14 | -51.14 |
PS Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio | -25.41 | 77.39 | 301.83 | -15.50 | -52.18 | -38.62 | -44.11 |
P/FCF Ratio | -23.18 | -18.29 | -10.93 | -190.95 | -1694.65 | -124.57 | -62.66 |
P/OCF Ratio | -23.18 | -18.29 | -10.96 | -190.95 | -1694.65 | -124.57 | -62.66 |
OCF/S Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / Equity Ratio | -0.05 | 0.00 | 0.00 | -0.06 | -0.03 | -0.20 | -0.29 |
Quick Ratio | 0.06 | 0.69 | 0.60 | 0.01 | 0.02 | 0.01 | 0.57 |
Current Ratio | 0.06 | 0.69 | 0.60 | 0.01 | 0.02 | 0.01 | 0.57 |
Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | -20.34 | -38.37 | -43.52 | -2.46 | -1.28 | -0.81 | -1.62 |
Return on Equity (ROE) | 137.79% | -502.79% | -2202.50% | 31.85% | 88.27% | 58.40% | 86.26% |
Return on Assets (ROA) | -659.14% | -177.82% | -207.23% | -236.17% | -782.15% | -3534.02% | -290.94% |
Return on Capital (ROIC) | 194.42% | -261.66% | -352.86% | 38.37% | 125.71% | 151.99% | -444.20% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |